Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 3
1991 1
1996 1
1997 1
2000 1
2003 1
2004 1
2005 2
2007 5
2008 3
2009 3
2010 2
2011 2
2012 2
2013 5
2014 4
2015 5
2016 6
2017 3
2018 11
2019 9
2020 12
2021 12
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

85 results
Results by year
Filters applied: . Clear all
Page 1
Determinants of COVID-19 disease severity in patients with cancer.
Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, Bogler Y, Caldararo M, Figueroa CJ, Glickman MS, Joanow A, Kaltsas A, Lee YJ, Lucca A, Mariano A, Morjaria S, Nawar T, Papanicolaou GA, Predmore J, Redelman-Sidi G, Schmidt E, Seo SK, Sepkowitz K, Shah MK, Wolchok JD, Hohl TM, Taur Y, Kamboj M. Robilotti EV, et al. Among authors: papanicolaou ga. Nat Med. 2020 Aug;26(8):1218-1223. doi: 10.1038/s41591-020-0979-0. Epub 2020 Jun 24. Nat Med. 2020. PMID: 32581323 Free PMC article.
Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study.
Papanicolaou GA, Silveira FP, Langston AA, Pereira MR, Avery RK, Uknis M, Wijatyk A, Wu J, Boeckh M, Marty FM, Villano S. Papanicolaou GA, et al. Clin Infect Dis. 2019 Apr 8;68(8):1255-1264. doi: 10.1093/cid/ciy706. Clin Infect Dis. 2019. PMID: 30329038 Free PMC article. Clinical Trial.
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience.
Lin A, Maloy M, Su Y, Bhatt V, DeRespiris L, Griffin M, Lau C, Proli A, Barker J, Shaffer B, Giralt SA, Jakubowski AA, Papadopoulos EB, Papanicolaou GA, Seo SK, Perales MA. Lin A, et al. Among authors: papanicolaou ga. Transpl Infect Dis. 2019 Dec;21(6):e13187. doi: 10.1111/tid.13187. Epub 2019 Oct 21. Transpl Infect Dis. 2019. PMID: 31585500 Free PMC article.
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results from a Phase 3 Randomized Clinical Trial.
Avery RK, Alain S, Alexander BD, Blumberg EA, Chemaly RF, Cordonnier C, Duarte RF, Florescu DF, Kamar N, Kumar D, Maertens J, Marty FM, Papanicolaou GA, Silveira FP, Witzke O, Wu J, Sundberg AK, Fournier M; SOLSTICE Trial Investigators. Avery RK, et al. Among authors: papanicolaou ga. Clin Infect Dis. 2021 Dec 2:ciab988. doi: 10.1093/cid/ciab988. Online ahead of print. Clin Infect Dis. 2021. PMID: 34864943
Determinants of Severity in Cancer Patients with COVID-19 Illness.
Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, Bogler Y, Caldararo M, Figueroa-Ortiz C, Glickman M, Joanow A, Kaltsas A, Lee YJ, Lucca Bianchi A, Mariano A, Morjaria S, Nawar T, Papanicolaou GA, Predmore J, Redelman-Sidi G, Schmidt E, Seo SK, Sepkowitz K, Shah M, Wolchok JD, Hohl TM, Taur Y, Kamboj M. Robilotti EV, et al. Among authors: papanicolaou ga. medRxiv. 2020 May 8:2020.05.04.20086322. doi: 10.1101/2020.05.04.20086322. Preprint. medRxiv. 2020. PMID: 32511541 Free PMC article. Updated.
85 results